ALPS Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$596K Buy
3,184
+1,008
+46% +$185K ﹤0.01% 898
2026
Q1
$411K Sell
2,176
-210
-9% -$44.2K ﹤0.01% 948
2025
Q4
$474K Buy
2,386
+26
+1% +$5.25K ﹤0.01% 771
2025
Q3
$479K Buy
+2,360
New +$419K ﹤0.01% 698
2025
Q1
Sell
-2,167
Closed -$274K 1119
2024
Q4
$274K Hold
2,167
﹤0.01% 944
2024
Q3
$360K Sell
2,167
-1,396
-39% -$211K ﹤0.01% 815
2024
Q2
$474K Sell
3,563
-17
-0.5% -$2.05K ﹤0.01% 586
2024
Q1
$376K Buy
+3,580
New +$322K ﹤0.01% 682

Other funds holding THC

ALPS Advisors's THC Position: Q2 2026 in Review

ALPS Advisors increased its Tenet Healthcare (THC) stake by 46% in Q2 2026, buying an estimated $185K and bringing the position to 3,184 shares worth $596K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

ALPS Advisors first reported a position in THC in Q1 2024 and has held it in 8 quarters since. 334 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • ALPS Advisors held 3,184 shares of Tenet Healthcare worth $596K as of Q2 2026.
  • ALPS Advisors bought 1,008 Tenet Healthcare shares in Q2 2026, an estimated $185K.
  • Tenet Healthcare made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #898 holding.
  • ALPS Advisors first reported a position in Tenet Healthcare in Q1 2024 and has held it in 8 quarters since.
  • 334 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.